scholarly article | Q13442814 |
P50 | author | Elizabeth Bukusi | Q60489118 |
Craig R Cohen | Q60622809 | ||
King K. Holmes | Q90437732 | ||
Lisa E. Manhart | Q121088561 | ||
P2093 | author name string | Robert C Brunham | |
Patricia A Totten | |||
Job J Bwayo | |||
Sabina Astete | |||
Samuel K Sinei | |||
P2860 | cites work | Mycoplasma genitalium in the cervices of Japanese women | Q37882938 |
Serological evidence implicating Mycoplasma genitalium in pelvic inflammatory disease | Q37905702 | ||
Significance of antibodies to Mycoplasma genitalium in salpingitis | Q68161267 | ||
P433 | issue | 9308 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Mycoplasma genitalium | Q1930909 |
acute endometritis | Q18557633 | ||
P304 | page(s) | 765-6 | |
P577 | publication date | 2002-03-02 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Association between Mycoplasma genitalium and acute endometritis | |
P478 | volume | 359 |
Q64110419 | "It's not a time spent issue, it's a 'what have you spent your time doing?' issue…" A qualitative study of UK patient opinions and expectations for implementation of Point of Care Tests for sexually transmitted infections and antimicrobial resistan |
Q33810064 | 'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women' |
Q38922868 | 2016 European guideline on Mycoplasma genitalium infections |
Q37572093 | A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London |
Q33919118 | A novel polymerase chain reaction assay to detect Mycoplasma genitalium. |
Q37857878 | A retrospective audit of the management and complications of pelvic inflammatory disease |
Q34595987 | A serine/threonine phosphatase encoded by MG_207 of Mycoplasma genitalium is critical for its virulence |
Q37006345 | A serological study of the role of Mycoplasma genitalium in pelvic inflammatory disease and ectopic pregnancy |
Q36804189 | A triacylated lipoprotein from Mycoplasma genitalium activates NF-kappaB through Toll-like receptor 1 (TLR1) and TLR2. |
Q36553850 | Abnormal vaginal pH and Mycoplasma genitalium infection |
Q42276397 | Alarming incidence of genital mycoplasmas among HIV-1-infected MSM in Jiangsu, China |
Q37191589 | Analysis identifying common and distinct sequences among Texas clinical strains of Mycoplasma genitalium |
Q38772340 | Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium |
Q36321280 | Association of Mycoplasma genitalium with infertility in North Indian women |
Q35586942 | Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease |
Q35530456 | Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease |
Q46260038 | Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance |
Q38949023 | Background review for the 2016 European guideline on Mycoplasma genitalium infections |
Q54614037 | Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium. |
Q40800022 | Changes in the etiology of sexually transmitted diseases in Botswana between 1993 and 2002: implications for the clinical management of genital ulcer disease |
Q37421341 | Chlamydial infection and spatial ascension of the female genital tract: a novel hybrid cellular automata and continuum mathematical model |
Q37119362 | Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease |
Q37419674 | Comparison of multiplex PCR assay with culture for detection of genital mycoplasmas |
Q35073368 | Comparison of transcription-mediated amplification and PCR assay results for various genital specimen types for detection of Mycoplasma genitalium |
Q36236663 | Comprehensive assessment of sociodemographic and behavioral risk factors for Mycoplasma genitalium infection in women |
Q36216576 | Correlates of cervical Mycoplasma genitalium and risk of preterm birth among Peruvian women |
Q34747682 | Detection of Mycoplasma genitalium by PCR amplification of the 16S rRNA gene |
Q35531997 | Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis |
Q85022280 | Detection of Mycoplasma genitalium using a wireless magnetoelastic immunosensor |
Q54751509 | Development and Performance of a Microwell-Plate-Based Polymerase Chain Reaction Assay for Mycoplasma genitalium |
Q33884960 | Development of a quantitative real-time PCR assay for detection of Mycoplasma genitalium. |
Q37346157 | Diagnosis and treatment of pelvic inflammatory disease. |
Q35552784 | Diagnostic assessment of Mycoplasma genitalium in culture-positive women |
Q45138939 | Diversity of cervicovaginal microbiota associated with female lower genital tract infections |
Q36580740 | Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease? |
Q88995637 | Does the Sex Risk Quiz Predict Mycoplasma genitalium Infection in Urban Adolescents and Young Adult Women? |
Q37838057 | Effect of cytokine level variations in individuals on the progression and outcome of bacterial urogenital infections--a meta-analysis |
Q35224082 | Endometrial histopathology in patients with laparoscopic proven salpingitis and HIV-1 infection |
Q36441494 | Epidemiology, pathogenesis and treatment of pelvic inflammatory disease. |
Q37132075 | Evaluation of the Hologic Panther Transcription-Mediated Amplification Assay for Detection of Mycoplasma genitalium |
Q37611991 | Experimental Infection of Pig-Tailed Macaques (Macaca nemestrina) with Mycoplasma genitalium |
Q34591252 | Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. |
Q36971250 | Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium |
Q36098434 | Functional analysis of the Mycoplasma genitalium MG312 protein reveals a specific requirement of the MG312 N-terminal domain for gliding motility |
Q33875386 | High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix |
Q39109644 | High prevalence of Mycoplasma genitalium among female sex workers in Honduras: implications for the spread of HIV and other sexually transmitted infections |
Q30820940 | Identification and characterization of immunogenic proteins of mycoplasma genitalium. |
Q37235788 | Identification of novel microbes associated with pelvic inflammatory disease and infertility |
Q33797838 | In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains |
Q34721011 | Intrastrain heterogeneity of the mgpB gene in Mycoplasma genitalium is extensive in vitro and in vivo and suggests that variation is generated via recombination with repetitive chromosomal sequences |
Q37839814 | Large two-centre study into the prevalence of Mycoplasma genitalium and Trichomonas vaginalis in the Netherlands |
Q26796722 | Management of Mycoplasma genitalium infections - can we hit a moving target? |
Q34257355 | Methionine sulfoxide reductase A (MsrA) deficient Mycoplasma genitalium shows decreased interactions with host cells |
Q27009515 | Microbial antigenic variation mediated by homologous DNA recombination |
Q28305224 | Microbiota and pelvic inflammatory disease |
Q36043585 | Multiplex Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance Using PlexZyme and PlexPrime Technology |
Q81353196 | Mycoplasma genitalium |
Q34190405 | Mycoplasma genitalium PCR: does freezing of specimens affect sensitivity? |
Q35056772 | Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. |
Q56057553 | Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection |
Q33771940 | Mycoplasma genitalium among young, urban pregnant women |
Q37183482 | Mycoplasma genitalium and preterm delivery at an urban community health center |
Q34076727 | Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics |
Q36551175 | Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment |
Q37253442 | Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women |
Q38609855 | Mycoplasma genitalium in Women: Current Knowledge and Research Priorities for This Recently Emerged Pathogen |
Q37186755 | Mycoplasma genitalium infection among HIV-positive women: prevalence, risk factors and association with vaginal shedding |
Q28083641 | Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis |
Q36192824 | Mycoplasma genitalium infection in women attending a sexually transmitted infection clinic: diagnostic specimen type, coinfections, and predictors |
Q42355223 | Mycoplasma genitalium infections: current treatment options and resistance issues |
Q39293657 | Mycoplasma genitalium is associated with increased genital HIV type 1 RNA in Zimbabwean women |
Q43136741 | Mycoplasma genitalium symptoms, concordance and treatment in high-risk sexual dyads |
Q35008363 | Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey |
Q37099478 | Mycoplasma genitalium-encoded MG309 activates NF-kappaB via Toll-like receptors 2 and 6 to elicit proinflammatory cytokine secretion from human genital epithelial cells |
Q36930455 | Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline |
Q36317299 | Mycoplasma genitalium: an efficient strategy to generate genetic variation from a minimal genome |
Q35659940 | Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease |
Q21131426 | Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women |
Q36728677 | Mycoplasma genitalium: an emerging sexually transmitted pathogen. |
Q35573004 | Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers |
Q35090137 | Mycoplasma genitalium: from Chrysalis to multicolored butterfly |
Q37136511 | Mycoplasma genitalium: prevalence and behavioural risk factors in the general population |
Q35532036 | Mycoplasma genitalium: prevalence, clinical significance, and transmission |
Q35542157 | Mycoplasma genitalium: should we treat and how? |
Q35608986 | Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases |
Q34097662 | Mycoplasmas and ureaplasmas as neonatal pathogens |
Q37848576 | Mycoplasmateceae species are not found in Fallopian tubes of women with tubo-peritoneal infertility. |
Q36753460 | Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. |
Q37849392 | Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management |
Q34387781 | Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment |
Q37845477 | Pelvic inflammatory disease: identifying research gaps--proceedings of a workshop sponsored by Department of Health and Human Services/National Institutes of Health/National Institute of Allergy and Infectious Diseases, November 3-4, 2011. |
Q37036116 | Persistence, immune response, and antigenic variation of Mycoplasma genitalium in an experimentally infected pig-tailed macaque (Macaca nemestrina). |
Q35108563 | Prevalence of Mycoplasma genitalium and Mycoplasma hominis in urogenital tract of Brazilian women |
Q44090938 | Prevalence of Mycoplasma genitalium in early pregnancy and relationship between its presence and pregnancy outcome |
Q37856406 | Prevalence of Mycoplasma genitalium in health clinic attendees complaining of vaginal discharge in Bangladesh |
Q37854179 | Prevalence of genital mycoplasmas, ureaplasmas and chlamydia in pregnancy |
Q37182074 | Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male patients at the San Francisco STD clinic, 2005-2006 |
Q33721540 | Prospective Evaluation of ResistancePlus MG, a New Multiplex Quantitative PCR Assay for Detection of Mycoplasma genitalium and Macrolide Resistance |
Q34430738 | Proximal region of the gene encoding cytadherence-related protein permits molecular typing of Mycoplasma genitalium clinical strains by PCR-restriction fragment length polymorphism |
Q36162075 | RecA mediates MgpB and MgpC phase and antigenic variation in Mycoplasma genitalium, but plays a minor role in DNA repair |
Q34269050 | Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium |
Q36044428 | Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decade |
Q37835223 | Relationship between Chlamydia trachomatis and Mycoplasma genitalium infection and pregnancy rate and outcome in Iranian infertile couples |
Q89633246 | Reviewing the Composition of Vaginal Microbiota: Inclusion of Nutrition and Probiotic Factors in the Maintenance of Eubiosis |
Q34296045 | Risk factors for Mycoplasma genitalium infection among female sex workers: a cross-sectional study in two cities in southwest China |
Q33900415 | Semen culture and the assessment of genitourinary tract infections. |
Q34719702 | Sequence-based typing of Mycoplasma genitalium reveals sexual transmission |
Q35671891 | Sexually transmissible infections other than HIV. |
Q34479272 | Sexually transmitted diseases treatment guidelines, 2015. |
Q33355815 | Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system |
Q47140897 | Should we screen for the sexually-transmitted infection Mycoplasma genitalium? Evidence synthesis using a transmission-dynamic model |
Q35572958 | Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection |
Q35531416 | Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis |
Q38560388 | The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis |
Q34261217 | The evolution of Mycoplasma genitalium. |
Q49427935 | The prevalence of, and risk factors for, mycoplasma genitalium infection among infertile women in Ibadan: A cross-sectional study |
Q34245136 | Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis |
Q35052845 | Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin |
Q21133562 | Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic |
Q21296776 | Treatment of acute pelvic inflammatory disease |
Q48077493 | mgpB and mgpC sequence diversity in Mycoplasma genitalium is generated by segmental reciprocal recombination with repetitive chromosomal sequences |
Search more.